Lakefront Receives Transparency Notification from Bank of America
Bank of America Corporation has crossed the 10% voting rights threshold in Lakefront Biotherapeutics following the acquisition of voting rights and equivalent financial instruments. As of August 18, 2026, Bank of America owns 1,419,144 direct voting rights (2.15%) and 5,243,453 equivalent financial instruments (7.96%), totaling 10.11% of Lakefront's 65,897,071 outstanding shares.